La réduction des risques et des dommages - Rapport d’orientation et recommandations de la commission d’audition. La réduction des risques et des dommages liés aux conduites addictives. Fédération-Française-d‛Addictologie. : . 2016(Cairn.info, ).Report
Trajectories of Unhealthy Behaviors in Midlife and Risk of Disability at Older Ages in the Whitehall II Cohort Study. Artaud, F.; Sabia, S.; Dugravot, A.; Kivimaki, M.; Singh-Manoux, A.; Elbaz, A.. J Gerontol A Biol Sci Med Sci.. 2016; 1500-1506: p.1500-1506Article
Developmental Coordination Disorder, An Umbrella Term for Motor Impairments in Children: Nature and Co-Morbid Disorders. Vaivre-Douret, Laurence; Lalanne, Christophe; Golse, Bernard. Frontiers in Psychology. 2016; 502: p.502. doi:10.3389/fpsyg.2016.00502Article
Core deficits and quality of survival after childhood medulloblastoma: a review: Table 1.. Chevignard, Mathilde; Câmara-Costa, Hugo; Doz,, François; Dellatolas, Georges. Neuro-Oncology Practice. 2016; npw013: p.npw013. doi:10.1093/nop/npw013Article
Quelles comorbidités psychiatriques dans la dépendance au cannabis à l'adolescence ? Comparaison de patients consultants et de témoins [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls]. Dorard, G.; Bungener, C.; Phan, O.; Edel, Y.; Corcos, M.; Berthoz, S.. L'Encephale. 2016; : . doi:10.1016/j.encep.2016.05.013Article
Genetic and environmental aetiology of the dimensions of Callous-Unemotional traits. Henry, J.; Pingault, J.-B.; Boivin, M.; Rijsdijk, F.; Viding, E.. Psychological Medicine. 2016; 405-414: p.405-414. doi:10.1017/S0033291715001919Article
Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy?. Wyatt, Christina M.; Drüeke, Tilman B.. Kidney International. 2016; 7-9: p.7-9. doi:10.1016/j.kint.2015.11.012Article
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R.. Mod Pathol. 2016; 1155-64: p.1155-64. doi:10.1038/modpathol.2016.109 10.1038/modpathol.2016.109. Epub 2016 Jul 1.Article
Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort. Grelaud, Angela; Fourrier-Réglat, Annie; Fitoussi, Olivier; Facon, Thierry; Jové, Jérémy; Bénichou, Jacques; Robinson, Philip; Marit, Gérald; Rouyer, Magali; Moore, Nicholas; Noize, Pernelle; VESUVE Study Group. Leukemia & Lymphoma. 2016; 57: p.1349-1354. doi:10.3109/10428194.2015.1096354Article
Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma. Gorphe, P.; Matias, M.; Even, C.; Ferte, C.; Bidault, F.; Garcia, G.; Temam, S.; Nguyen, F.; Blanchard, P.; Tao, Y.; Janot, F.. Anticancer Res. 2016; 6625-6630: p.6625-6630. doi:10.21873/anticanres.11269 10.21873/anticanres.11269.Article